Ocuphire Pharma Inc (OCUP)
1.68
-0.06
(-3.17%)
USD |
NASDAQ |
May 17, 16:00
1.68
0.00 (0.00%)
After-Hours: 20:00
Ocuphire Pharma Shareholders Equity (Quarterly): 46.06M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 46.06M |
| December 31, 2023 | 49.91M |
| September 30, 2023 | 50.28M |
| June 30, 2023 | 37.70M |
| March 31, 2023 | 41.25M |
| December 31, 2022 | 46.24M |
| September 30, 2022 | 11.88M |
| Date | Value |
|---|---|
| June 30, 2022 | 14.60M |
| March 31, 2022 | 17.27M |
| December 31, 2021 | 22.22M |
| September 30, 2021 | 20.57M |
| June 30, 2021 | 22.55M |
| March 31, 2021 | 9.816M |
| December 31, 2020 | -13.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.47M
Minimum
Dec 2020
50.28M
Maximum
Sep 2023
26.92M
Average
22.39M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.84M |
| Total Liabilities (Quarterly) | 5.787M |
| Current Ratio | 8.959 |